These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9879479)

  • 41. 5 alpha-reductase and finasteride in pattern alopecia and acne.
    Burkhart CG; Burkhart CN
    J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
    [No Abstract]   [Full Text] [Related]  

  • 42. Minoxidil vs finasteride in the treatment of men with androgenetic alopecia.
    Saraswat A; Kumar B
    Arch Dermatol; 2003 Sep; 139(9):1219-21. PubMed ID: 12975174
    [No Abstract]   [Full Text] [Related]  

  • 43. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.
    Price VH; Menefee E; Sanchez M; Ruane P; Kaufman KD
    J Am Acad Dermatol; 2002 Apr; 46(4):517-23. PubMed ID: 11907500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of Postoperative Finasteride Therapy on Recurrence of Gynecomastia After Mastectomy in Men Taking Finasteride for Alopecia.
    Lee SG; Park PJ; Lee SR; Koo BH; Byun GY; Kim MJ; Kang HJ; Kim S; Oh BS; Lee YH
    Am J Mens Health; 2019; 13(5):1557988319871423. PubMed ID: 31552775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Androgenetic alopecia and current methods of treatment.
    Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic hotline. Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics.
    Keene S; Goren A
    Dermatol Ther; 2011; 24(2):296-300. PubMed ID: 21410621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Androgenetic alopecia: an update.
    Kaliyadan F; Nambiar A; Vijayaraghavan S
    Indian J Dermatol Venereol Leprol; 2013; 79(5):613-25. PubMed ID: 23974579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 'Post-finasteride syndrome': what to tell our female patients?
    Mervis JS; Borda LJ; Miteva M
    Br J Dermatol; 2018 Sep; 179(3):785-786. PubMed ID: 29624646
    [No Abstract]   [Full Text] [Related]  

  • 49. [Finasteride adverse effects: An update].
    Carreño-Orellana N; Moll-Manzur C; Carrasco-Zuber JE; Álvarez-Véliz S; Berroeta-Mauriziano D; Porras-Kusmanic N
    Rev Med Chil; 2016 Dec; 144(12):1584-1590. PubMed ID: 28393993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic experience with oral finasteride for androgenetic alopecia in female-to-male transgender patients.
    Moreno-Arrones OM; Becerra A; Vano-Galvan S
    Clin Exp Dermatol; 2017 Oct; 42(7):743-748. PubMed ID: 28691187
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Finasteride: middle-age cure-all for alopecia and benign prostatic hyperplasia?
    Federman DG
    Mayo Clin Proc; 2006 Feb; 81(2):267; author reply 267-8. PubMed ID: 16471089
    [No Abstract]   [Full Text] [Related]  

  • 52. Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
    Belknap SM; Aslam I; Kiguradze T; Temps WH; Yarnold PR; Cashy J; Brannigan RE; Micali G; Nardone B; West DP
    JAMA Dermatol; 2015 Jun; 151(6):600-6. PubMed ID: 25830296
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Female androgenetic alopecia treated by finasteride: a case forward.
    Valsecchi R; Leghissa P; Riva M
    Acta Derm Venereol; 2004; 84(6):488-9. PubMed ID: 15844649
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.
    Jung JY; Yeon JH; Choi JW; Kwon SH; Kim BJ; Youn SW; Park KC; Huh CH
    Int J Dermatol; 2014 Nov; 53(11):1351-7. PubMed ID: 24898559
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Finasteride and the Uncertainties of Establishing Harms.
    Moore TJ
    JAMA Dermatol; 2015 Jun; 151(6):585-6. PubMed ID: 25831198
    [No Abstract]   [Full Text] [Related]  

  • 56. Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
    Coskuner ER; Ozkan B; Culha MG
    Sex Med Rev; 2019 Apr; 7(2):277-282. PubMed ID: 30301703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia.
    Caserini M; Radicioni M; Leuratti C; Terragni E; Iorizzo M; Palmieri R
    Int J Clin Pharmacol Ther; 2016 Jan; 54(1):19-27. PubMed ID: 26636418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversible myopathy and ophthalmoparesis after low-dose finasteride administration for androgenic alopecia.
    Ryu HJ; Kwon DY
    Dermatol Surg; 2014 May; 40(5):595-7. PubMed ID: 24533595
    [No Abstract]   [Full Text] [Related]  

  • 59. Finasteride and androgenic alopecia; from therapeutic options to medical implications.
    Motofei IG; Rowland DL; Tampa M; Sarbu MI; Mitran MI; Mitran CI; Stoian AP; Diaconu CC; Paunica S; Georgescu SR
    J Dermatolog Treat; 2020 Jun; 31(4):415-421. PubMed ID: 30897009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iatrogenic androgenetic alopecia in a male phenotype 46XX true hermaphrodite.
    Paik SH; Cho HH; Jeon HC; Jo SJ; Kwon OS
    Br J Dermatol; 2012 Jan; 166(1):221-2. PubMed ID: 21729028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.